The elevation in plasma alpha-synuclein level was associated with cognitive decline in Parkinson’s disease [46], whereas an elevation in alpha-synuclein gave rise to neurodegeneration in Parkinson’s disease [13], and this substance was used as a serum marker for the early diagnosis of Parkinson’s disease [9]. Here, SNCA is linked to Parkinson disease.